CURRENT
ISSUE1574
June 17, 2019
Mild to moderate psoriasis can be treated with topical
drugs or with phototherapy. Patients with moderate to
severe disease generally require systemic therapy. read more...
More from issue 1574
Featured Article
Coming Soon
Tafenoquine (Arakoda and Krintafel) for Malaria
Colon Cancer Screening
Estradiol/Progesterone (Bijuva) for Menopause
Cyclosporine 0.09% Solution (Cequa) for Dry Eye Disease
Drugs for Tobacco Dependence
Recommend to Your Library
We're Essential. Begin your free trial
Previous Issues
June 3, 2019 (1573)
- Risankizumab (Skyrizi) for Psoriasis
- Romosozumab (Evenity) for Postmenopausal Osteoporosis
- Prucalopride (Motegrity) for Chronic Idiopathic Constipation
- Expanded Table: Some Drugs for Chronic Idiopathic Constipation (online only)
May 20, 2019 (1572)
- Inhaled Levodopa (Inbrija) for Parkinson's Disease
- Omadacycline (Nuzyra) - A New Tetracycline Antibiotic
- Emicizumab (Hemlibra) for Subcutaneous Prophylaxis in Hemophilia A
- PrabotulinumtoxinA (Jeuveau) for Frown Lines
May 6, 2019 (1571)
- Insulins for Type 2 Diabetes
- Brexanolone (Zulresso) for Postpartum Depression
- Siponimod (Mayzent) - A New Drug for Multiple Sclerosis
- In Brief: Tegaserod (Zelnorm) Returns
- Expanded Table: Some Available Insulins for Type 2 Diabetes (online only)
April 22, 2019 (1570)
- OTC Drugs for Seasonal Allergies
- Eravacycline (Xerava) - An IV Tetracycline for Complicated Intra-Abdominal Infections
- Ozenoxacin 1% Cream (Xepi) for Impetigo
April 8, 2019 (1569)
